Cite
MLA Citation
Neha Verma et al.. “NCMP-05. RITUXIMAB AS INITIAL THERAPY FOR THE REVERSAL OF MYASTHENIA GRAVIS NEUROTOXICITY CAUSED BY IPILIMUMAB/NIVOLUMAB.” Neuro-oncology, vol. 20, n.d., p. vi194. http://access.bl.uk/ark:/81055/vdc_100095323881.0x00001d